Sinha Parul, Pipkorn Patrik, Zenga Joseph, Haughey Bruce H
1 Department of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
2 Department of Head and Neck Surgery, Florida Hospital Celebration Health, Celebration, Florida, USA.
Ann Otol Rhinol Laryngol. 2017 May;126(5):357-364. doi: 10.1177/0003489417691297. Epub 2017 Feb 16.
The indications, techniques, and outcomes for a minimally invasive surgical approach in oropharyngeal squamous cell carcinoma (OPSCC) unsuitable for transoral resection are not well-described.
A retrospective case series was performed using a prospectively assembled database of transoral surgery-treated OPSCC patients who also underwent a "hybrid" approach of combined transoral and limited pharyngotomy for tumor resection. Disease and functional outcomes were evaluated.
Twenty patients underwent complete tumor resection using the hybrid approach. Median follow-up was 48 months. No postoperative pharyngocutaneous fistula occurred. One patient (5%) had a local recurrence. Kaplan-Meier estimates for disease-specific survival at 2 and 5 years were 94.4% (95% CI, 84%-100%) and 87% (95% CI, 70%-100%). All but 1 patient (due to chemoradiotherapy-related chondroradionecrosis) were decannulated, and 2 required long-term gastrostomy.
In the absence of a favorable transoral access, the "hybrid" approach of combined transoral and limited pharyngotomy can accomplish margin-negative primary tumor resection, with a high degree of disease control and functional recovery in selected OPSCC patients.
对于不适用于经口切除的口咽鳞状细胞癌(OPSCC),微创外科手术方法的适应症、技术及结果尚未得到充分描述。
采用前瞻性收集的经口手术治疗的OPSCC患者数据库进行回顾性病例系列研究,这些患者还接受了经口联合有限咽切开术的“混合”方法进行肿瘤切除。评估疾病和功能结果。
20例患者采用混合方法实现了肿瘤完全切除。中位随访时间为48个月。未发生术后咽皮瘘。1例患者(5%)出现局部复发。2年和5年疾病特异性生存的Kaplan-Meier估计值分别为94.4%(95%CI,84%-100%)和87%(95%CI,70%-100%)。除1例患者(由于放化疗相关的软骨放射性坏死)外,所有患者均拔除气管套管,2例患者需要长期胃造瘘。
在没有良好经口入路的情况下,经口联合有限咽切开术的“混合”方法可以实现切缘阴性的原发性肿瘤切除,在部分OPSCC患者中具有高度的疾病控制和功能恢复效果。